[go: up one dir, main page]

Wang, 2015 - Google Patents

Effects of cigarette smoke on killer cell activation in chronic obstructive pulmonary disease

Wang, 2015

View PDF
Document ID
16756343116894441575
Author
Wang J
Publication year

External Links

Snippet

FCS Foetal calf serum FEV1 forced expiratory volume in one second FGF fibroblast growth factors FITC fluorescein isothiocyanate FMO fluorescence minus one FVC forced vital capacity α-Galcer α-galactosylceramide G-CSF granulocyte colony-stimulating factor GM …
Continue reading at core.ac.uk (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Similar Documents

Publication Publication Date Title
Chiu et al. Acquired natural killer cell dysfunction in the tumor microenvironment of classic Hodgkin lymphoma
Toubai et al. Danger signals and graft-versus-host disease: current understanding and future perspectives
Lugo-Villarino et al. The C-type lectin receptor DC-SIGN has an anti-inflammatory role in human M (IL-4) macrophages in response to Mycobacterium tuberculosis
Robb et al. Type I-IFNs control GVHD and GVL responses after transplantation
Li et al. IL-27/IFN-γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages
Rosenberg et al. Eosinophils: changing perspectives in health and disease
Pontrelli et al. The role of natural killer cells in the immune response in kidney transplantation
Correia et al. Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells
Ghiringhelli et al. CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
Walzer et al. Natural-killer cells and dendritic cells:“l'union fait la force”
Liu et al. Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms
Barlow et al. Innate lymphoid cells of the lung
Balhara et al. Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival
Konjević et al. Natural killer cell receptors: alterations and therapeutic targeting in malignancies
Chiu et al. The host environment is responsible for aging-related functional NK cell deficiency
Fischer et al. The Smac mimetic BV6 improves NK cell-mediated killing of rhabdomyosarcoma cells by simultaneously targeting tumor and effector cells
Mammadli et al. Targeting interleukin-2-inducible T-cell kinase (ITK) differentiates GVL and GVHD in allo-HSCT
Matsushita et al. Regnase-1 degradation is crucial for IL-33–and IL-25–mediated ILC2 activation
Wang et al. Efficiency and toxicity of ruxolitinib as a salvage treatment for steroid-refractory chronic graft-versus-host disease
US20240398695A1 (en) Methods of T Cell Expansion and Activation
Peebles At the bedside: the emergence of group 2 innate lymphoid cells in human disease
Brilot et al. NK cells interactions with dendritic cells shape innate and adaptive immunity
WO2017127706A1 (en) Compositions and methods for inhibiting dkk-1
Wang Effects of cigarette smoke on killer cell activation in chronic obstructive pulmonary disease
Hammond‐Mckibben et al. Characterization of factors regulating successful immunotherapy using a tumor‐specific cytotoxic T lymphocyte clone: Role of interleukin‐2, cycling pattern of lytic activity and adhesion molecules